|
TFAM expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.06540332112104E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.05622194218813E-12 |
| Normal-vs-Stage2 |
8.182600E-03 |
| Normal-vs-Stage3 |
3.182300E-02 |
| Normal-vs-Stage4 |
2.797200E-01 |
| Stage1-vs-Stage2 |
3.440000E-01 |
| Stage1-vs-Stage3 |
1.057770E-01 |
| Stage1-vs-Stage4 |
6.333800E-02 |
| Stage2-vs-Stage3 |
7.056200E-01 |
| Stage2-vs-Stage4 |
3.176200E-01 |
| Stage3-vs-Stage4 |
5.634600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.93485285757833E-12 |
| Normal-vs-AfricanAmerican |
1.68631999999391E-05 |
| Normal-vs-Asian |
3.185000E-01 |
| Caucasian-vs-AfricanAmerican |
6.327600E-01 |
| Caucasian-vs-Asian |
6.866800E-01 |
| AfricanAmerican-vs-Asian |
8.381800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.67954539165294E-12 |
| Normal-vs-Female |
6.395800E-03 |
| Male-vs-Female |
1.740830E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.63840000000359E-06 |
| Normal-vs-Extreme_Weight |
1.15352172258554E-13 |
| Normal-vs-Obese |
2.32669999999935E-05 |
| Normal-vs-Extreme_Obese |
2.023800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.885400E-01 |
| Normal_Weight-vs-Obese |
2.449200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.023800E-01 |
| Extreme_Weight-vs-Obese |
2.236400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.319200E-01 |
| Obese-vs-Extreme_Obese |
9.385000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.190800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.23160004206602E-09 |
| Normal-vs-Age(61-80Yrs) |
1.54519730344305E-11 |
| Normal-vs-Age(81-100Yrs) |
2.378800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.645780E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.459900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.858000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.853570E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.400000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.090000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.67754699020861E-12 |
| Normal-VS-Type2 PRCC |
6.70910000000191E-07 |
| Normal-VS-KIRP CIMP |
2.808000E-01 |
| Normal-VS-Unclassified PRCC |
3.967900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.760410E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.821400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.658620E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.033700E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
7.908800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.002900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.7683967885348E-11 |
| Normal-vs-N1 |
5.336400E-01 |
| Normal-vs-N2 |
3.132600E-01 |
| N0-vs-N1 |
2.223000E-04 |
| N0-vs-N2 |
6.720200E-01 |
| N1-vs-N2 |
2.663200E-01 |
|
|
